Randomized phase II study comparing the met inhibitor cabozantinib to temozolomide (tmz) or dacarbazine (dtic) in ocular melanoma - A091201
- Citation:
- J Clin Oncol vol 33 (suppl) abstr TPS9087
- Meeting Instance:
- ASCO 2015
- Year:
- 2015
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- No-Endpoint
- Analysis:
- Trial-Description-Only
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 3092
- Program:
- OGC
- Primary Committee:
- Experimental
- Sec. Committees:
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- Jason J. Luke Jacob B. Allred Laura E. Horvath Bruno R. Bastos Charles Erlichman Gary K. Schwartz
- Networks:
- COLUMBIA, LAPS-MN026, LAPS-PA015
- Study
- Alliance-A091201
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: